Question 1

Does ProShare Advisors own IOVA stock?

Accepted Answer

Yes. As of its Q3 2026 13F, ProShare Advisors holds 65,672 shares of IOVA (Iovance Biotherapeutics), worth $973,259.

Question 2

How many shares of IOVA does ProShare Advisors own?

Accepted Answer

As of its Q3 2026 13F, ProShare Advisors holds 65,672 shares of IOVA (Iovance Biotherapeutics).

Question 3

What is ProShare Advisors' IOVA position worth?

Accepted Answer

As of its Q3 2026 13F, ProShare Advisors' IOVA position is worth $973,259.

Question 4

Is ProShare Advisors buying or selling IOVA?

Accepted Answer

In Q3 2026, ProShare Advisors reduced its IOVA position by 1,077 shares (-1.6%).

Question 5

When did ProShare Advisors first buy IOVA?

Accepted Answer

ProShare Advisors already held IOVA in its Q4 2018 13F, the earliest on record, and has listed it in 32 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Decreased	65,672	-1.6%	$973,259	0.0%	$14.82	0
2026-Q2	Decreased	66,749	-0.9%	$277,677	0.0%	$4.16	0
2026-Q1	Decreased	67,326	-8.7%	$236,314	0.0%	$3.51	0
2025-Q4	Increased	73,733	+28.1%	$201,291	0.0%	$2.73	28
2025-Q3	Decreased	57,539	-11.5%	$124,859	0.0%	$2.17	0
2025-Q2	Decreased	65,041	-12.4%	$111,871	0.0%	$1.72	0
2025-Q1	Decreased	74,240	-19.1%	$247,219	0.0%	$3.33	0
2024-Q4	Increased	91,775	+39.5%	$679,135	0.0%	$7.40	32
2024-Q3	Increased	65,779	+34.1%	$617,665	0.0%	$9.39	31